The information on this page is intended for journalists, press and media. Click YES to get to the newsroom. If you click NO you will come back to Mynewsdesk.com.
The Alder Hey Children’s NHS Foundation Trust and Isansys Lifecare have won funding from NHS England’s Transformation Directorate (formally NHSX) to create a hospital from home for acutely unwell children. Alder Hey Children’s NHS Foundation Trust, Liverpool, UK, has successfully trialled the state-of-the-art Patient Status Engine (PSE), a wireless patient monitoring system developed by Isansy
A world-leading children’s hospital has partnered with digital healthcare pioneers Isansys Lifecare as part of a trial to support at home patient monitoring and reduce pressures on the healthcare system.The collaboration will see Alder Hey Children’s NHS Foundation Trust, Liverpool, UK, making use of the state-of-the-art Patient Status Engine (PSE) - wireless patient monitoring system - as par
Rigorous clinical validation of AI and machine learning technologies is vital to ensure devices are fit for clinical use
A world-leading study at Birmingham Children’s Hospital has concluded that the use of a continuous wireless patient monitoring platform and a first-of-its-kind predictive indicator can aid detection of deterioration of paediatric patients significantly earlier than their current early warning scoring method. If adopted at scale, this new system could potentially save hundreds of young lives.
A new paediatric study has concluded that the use of the Patient Status Engine, a wireless and continuous patient monitoring platform, makes it easier and simpler to monitor an individual’s sleep state at home, enhancing quality of life.
A new study has concluded that the use of a continuous wireless patient monitoring platform which monitors a mother’s temperature during labor could aid detection of newborns at risk of the early onset of sepsis (EOS) faster than current practice, enabling earlier and more effective targeted treatment of affected infants
Covid-19 has been a wake-up call for the nation and the world. Healthcare providers have had to rapidly find new ways of working and now technologies developed over the last decade to enhance the remote patient/ physician relationship are now coming into their own. At Isansys, we are now completely prepared for this new beginning.
With a surge of UK and international orders for the Patient Status Engine, an advanced patient monitoring system, in the face of the Covid-19 pandemic, Isansys Lifecare is collaborating with Ricardo to scale up production as quickly as possible whilst also building longer-term capacity.
Research by BBC News this week showed that a quarter of patients with sepsis have experienced delays in getting treatment. Hospitals are supposed to put a person on an antibiotic drip within an hour if sepsis is suspected but research by BBC News suggests a quarter of patients in England wait longer. Delays raise the chance of potentially fatal complications such as organ failure and even death.
Can You Help Us Win The Prize ?
Isansys Lifecare, a digital healthcare company which has created and developed the world’s most advanced real-time patient data collection and analysis platform, has been granted a US patent covering a key feature of its Lifetouch cardiac sensor. The US patent adds to a suite of already issued European patents for the wireless smart patch device.The Lifetouch is a vital component of the Patien
Isansys to showcase its next generation of wearable technology and wireless patient monitoring platform in Manchester next month
When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.
To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.
Please note that our Terms of Use apply to all use of our services.
You can withdraw your consent at any time by unsubscribing or deleting your account.
Email sent to __email__. Click the link there to follow Isansys.